From genome to antivirals: SARS as a test tube
- 2 March 2005
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (5) , 345-352
- https://doi.org/10.1016/s1359-6446(04)03320-3
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 InhibitorHypertension, 2004
- Characterization of SARS‐CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence‐based assayFEBS Letters, 2004
- Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitorsBiochemical and Biophysical Research Communications, 2004
- HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirusBiochemical and Biophysical Research Communications, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 LineagePublished by Elsevier ,2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- LearnCoil-VMF: computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteinsJournal of Molecular Biology, 1999
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984